< Back to previous page
Patent
Citrullinated peptides for diagnosis or treatment of diabetes
The present invention relates to citrullinated peptide fragments of GRP78 for diagnosis or treatment of subjects with type 1 diabetes.
Patent Publication Number: WO2018046648
Year filing: 2017
Year approval: 2019
Year publication: 2018
Status: Requested
URI: link to Espacenet
Technology domains: Pharmaceuticals
Validated for IOF-key: Yes
Attributed to: Associatie KULeuven